nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—HRH1—atherosclerosis	0.565	1	CbGaD
Promazine—CYP2C19—Rosuvastatin—atherosclerosis	0.0364	0.121	CbGbCtD
Promazine—CYP2C19—Simvastatin—atherosclerosis	0.0338	0.113	CbGbCtD
Promazine—CYP2C19—Lovastatin—atherosclerosis	0.0331	0.11	CbGbCtD
Promazine—CYP2C9—Rosuvastatin—atherosclerosis	0.0302	0.101	CbGbCtD
Promazine—CYP2C9—Simvastatin—atherosclerosis	0.0281	0.0937	CbGbCtD
Promazine—CYP2C9—Lovastatin—atherosclerosis	0.0275	0.0916	CbGbCtD
Promazine—CYP2C9—Pravastatin—atherosclerosis	0.0275	0.0916	CbGbCtD
Promazine—CYP3A4—Rosuvastatin—atherosclerosis	0.0176	0.0586	CbGbCtD
Promazine—CYP3A4—Ezetimibe—atherosclerosis	0.0176	0.0586	CbGbCtD
Promazine—CYP3A4—Simvastatin—atherosclerosis	0.0164	0.0545	CbGbCtD
Promazine—CYP3A4—Pravastatin—atherosclerosis	0.016	0.0533	CbGbCtD
Promazine—CYP3A4—Lovastatin—atherosclerosis	0.016	0.0533	CbGbCtD
Promazine—Isothipendyl—HRH1—atherosclerosis	0.000515	0.0625	CrCbGaD
Promazine—Chloropyramine—HRH1—atherosclerosis	0.000452	0.0547	CrCbGaD
Promazine—Aceprometazine—HRH1—atherosclerosis	0.000446	0.0541	CrCbGaD
Promazine—Dexbrompheniramine—HRH1—atherosclerosis	0.000431	0.0522	CrCbGaD
Promazine—Pheniramine—HRH1—atherosclerosis	0.000422	0.0511	CrCbGaD
Promazine—Methdilazine—HRH1—atherosclerosis	0.000413	0.0501	CrCbGaD
Promazine—HTR2A—arteriole—atherosclerosis	0.000389	0.21	CbGeAlD
Promazine—Clofedanol—HRH1—atherosclerosis	0.000384	0.0465	CrCbGaD
Promazine—Doxylamine—HRH1—atherosclerosis	0.000351	0.0426	CrCbGaD
Promazine—Tripelennamine—HRH1—atherosclerosis	0.000334	0.0405	CrCbGaD
Promazine—Dimetindene—HRH1—atherosclerosis	0.000307	0.0372	CrCbGaD
Promazine—Alimemazine—HRH1—atherosclerosis	0.000301	0.0365	CrCbGaD
Promazine—Bromodiphenhydramine—HRH1—atherosclerosis	0.000275	0.0333	CrCbGaD
Promazine—Mequitazine—HRH1—atherosclerosis	0.000259	0.0314	CrCbGaD
Promazine—HTR2A—vein—atherosclerosis	0.000232	0.125	CbGeAlD
Promazine—Brompheniramine—HRH1—atherosclerosis	0.000198	0.024	CrCbGaD
Promazine—Chlorphenamine—HRH1—atherosclerosis	0.000194	0.0235	CrCbGaD
Promazine—Mesoridazine—HRH1—atherosclerosis	0.000182	0.0221	CrCbGaD
Promazine—Prochlorperazine—HRH1—atherosclerosis	0.000176	0.0214	CrCbGaD
Promazine—Fluphenazine—HRH1—atherosclerosis	0.000159	0.0193	CrCbGaD
Promazine—HTR2A—hindlimb—atherosclerosis	0.000154	0.0833	CbGeAlD
Promazine—Propiomazine—HRH1—atherosclerosis	0.000153	0.0186	CrCbGaD
Promazine—Chlorprothixene—HRH1—atherosclerosis	0.000145	0.0176	CrCbGaD
Promazine—Thioridazine—HRH1—atherosclerosis	0.000137	0.0167	CrCbGaD
Promazine—Trimipramine—HRH1—atherosclerosis	0.000134	0.0163	CrCbGaD
Promazine—HTR2A—appendage—atherosclerosis	0.000132	0.0714	CbGeAlD
Promazine—Diphenhydramine—HRH1—atherosclerosis	0.000132	0.016	CrCbGaD
Promazine—Methotrimeprazine—HRH1—atherosclerosis	0.000131	0.0159	CrCbGaD
Promazine—Promethazine—HRH1—atherosclerosis	0.000129	0.0157	CrCbGaD
Promazine—Doxepin—HRH1—atherosclerosis	0.000128	0.0155	CrCbGaD
Promazine—Trifluoperazine—HRH1—atherosclerosis	0.000127	0.0154	CrCbGaD
Promazine—Perphenazine—HRH1—atherosclerosis	0.000126	0.0153	CrCbGaD
Promazine—Orphenadrine—HRH1—atherosclerosis	0.000125	0.0151	CrCbGaD
Promazine—Quetiapine—HRH1—atherosclerosis	0.000124	0.015	CrCbGaD
Promazine—Desipramine—HRH1—atherosclerosis	0.000117	0.0142	CrCbGaD
Promazine—Tamoxifen—ESR2—atherosclerosis	0.000108	0.0131	CrCbGaD
Promazine—Chlorpromazine—HRH1—atherosclerosis	0.0001	0.0121	CrCbGaD
Promazine—Imipramine—HRH1—atherosclerosis	9.95e-05	0.0121	CrCbGaD
Promazine—Amitriptyline—HRH1—atherosclerosis	9.89e-05	0.012	CrCbGaD
Promazine—HTR2A—artery—atherosclerosis	9.44e-05	0.0511	CbGeAlD
Promazine—HTR2A—endothelium—atherosclerosis	7.98e-05	0.0431	CbGeAlD
Promazine—HTR2A—blood vessel—atherosclerosis	7.36e-05	0.0398	CbGeAlD
Promazine—CHRM2—cardiovascular system—atherosclerosis	6.79e-05	0.0367	CbGeAlD
Promazine—Tamoxifen—ESR1—atherosclerosis	6.65e-05	0.00806	CrCbGaD
Promazine—CHRM1—cardiovascular system—atherosclerosis	6.18e-05	0.0334	CbGeAlD
Promazine—Oxcarbazepine—ALB—atherosclerosis	5.86e-05	0.00711	CrCbGaD
Promazine—ADRA1A—cardiovascular system—atherosclerosis	5.08e-05	0.0274	CbGeAlD
Promazine—CHRM3—adipose tissue—atherosclerosis	4.88e-05	0.0264	CbGeAlD
Promazine—HRH1—connective tissue—atherosclerosis	4.52e-05	0.0244	CbGeAlD
Promazine—ADRA1A—adipose tissue—atherosclerosis	4.48e-05	0.0242	CbGeAlD
Promazine—ADRA2A—connective tissue—atherosclerosis	4.44e-05	0.024	CbGeAlD
Promazine—Acepromazine—ALB—atherosclerosis	4.43e-05	0.00537	CrCbGaD
Promazine—Thioproperazine—ALB—atherosclerosis	4.33e-05	0.00525	CrCbGaD
Promazine—Pipotiazine—ALB—atherosclerosis	4.26e-05	0.00516	CrCbGaD
Promazine—CYP2C9—cardiovascular system—atherosclerosis	3.98e-05	0.0215	CbGeAlD
Promazine—HTR2A—connective tissue—atherosclerosis	3.77e-05	0.0204	CbGeAlD
Promazine—HRH1—adipose tissue—atherosclerosis	3.47e-05	0.0187	CbGeAlD
Promazine—ADRA2A—adipose tissue—atherosclerosis	3.4e-05	0.0184	CbGeAlD
Promazine—Clomipramine—ALB—atherosclerosis	3.37e-05	0.00408	CrCbGaD
Promazine—HTR2A—cardiovascular system—atherosclerosis	3.28e-05	0.0177	CbGeAlD
Promazine—CYP2C19—liver—atherosclerosis	3.18e-05	0.0172	CbGeAlD
Promazine—ADRA1A—liver—atherosclerosis	3.14e-05	0.017	CbGeAlD
Promazine—CYP1A2—liver—atherosclerosis	2.6e-05	0.014	CbGeAlD
Promazine—CYP2C9—liver—atherosclerosis	2.46e-05	0.0133	CbGeAlD
Promazine—Chlorpromazine—ALB—atherosclerosis	2.31e-05	0.0028	CrCbGaD
Promazine—Amitriptyline—ALB—atherosclerosis	2.28e-05	0.00277	CrCbGaD
Promazine—HTR2A—liver—atherosclerosis	2.03e-05	0.011	CbGeAlD
Promazine—CYP3A4—liver—atherosclerosis	1.88e-05	0.0102	CbGeAlD
Promazine—CYP2C9—Metabolism—CD36—atherosclerosis	4.7e-06	3.76e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—VEGFA—atherosclerosis	4.7e-06	3.76e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.67e-06	3.73e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	4.66e-06	3.73e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—STAT3—atherosclerosis	4.65e-06	3.72e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—MAPK8—atherosclerosis	4.64e-06	3.71e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—AGT—atherosclerosis	4.64e-06	3.71e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	4.64e-06	3.71e-05	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—AKT1—atherosclerosis	4.63e-06	3.7e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	4.63e-06	3.7e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—HMOX1—atherosclerosis	4.62e-06	3.7e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	4.62e-06	3.69e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	4.61e-06	3.68e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	4.59e-06	3.67e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—INS—atherosclerosis	4.59e-06	3.67e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	4.58e-06	3.66e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	4.57e-06	3.65e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—APOE—atherosclerosis	4.55e-06	3.64e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	4.55e-06	3.63e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	4.53e-06	3.62e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	4.52e-06	3.61e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	4.51e-06	3.61e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—CAV1—atherosclerosis	4.51e-06	3.6e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—MAPK3—atherosclerosis	4.5e-06	3.6e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—VEGFA—atherosclerosis	4.5e-06	3.6e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—APOA1—atherosclerosis	4.5e-06	3.59e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—NOS3—atherosclerosis	4.49e-06	3.59e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.45e-06	3.56e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—STAT3—atherosclerosis	4.45e-06	3.56e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—MAPK3—atherosclerosis	4.44e-06	3.55e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	4.44e-06	3.55e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—APOB—atherosclerosis	4.43e-06	3.54e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—NOS3—atherosclerosis	4.42e-06	3.53e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—NOS3—atherosclerosis	4.41e-06	3.53e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—PTGS2—atherosclerosis	4.4e-06	3.52e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—NOS3—atherosclerosis	4.4e-06	3.52e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—NOS3—atherosclerosis	4.38e-06	3.5e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—TGFB1—atherosclerosis	4.37e-06	3.49e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PPARA—atherosclerosis	4.37e-06	3.49e-05	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	4.36e-06	3.49e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	4.34e-06	3.47e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	4.33e-06	3.46e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	4.32e-06	3.46e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—TGFB1—atherosclerosis	4.31e-06	3.45e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—GSTM1—atherosclerosis	4.31e-06	3.44e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—IL6—atherosclerosis	4.29e-06	3.43e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—VEGFA—atherosclerosis	4.29e-06	3.43e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	4.26e-06	3.4e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—STAT3—atherosclerosis	4.24e-06	3.39e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—AGT—atherosclerosis	4.23e-06	3.38e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	4.23e-06	3.38e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—LPL—atherosclerosis	4.23e-06	3.38e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	4.21e-06	3.37e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	4.19e-06	3.35e-05	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	4.18e-06	3.34e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.16e-06	3.32e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—APOE—atherosclerosis	4.15e-06	3.32e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	4.13e-06	3.3e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—GPX1—atherosclerosis	4.13e-06	3.3e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	4.11e-06	3.29e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—CAV1—atherosclerosis	4.11e-06	3.29e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	4.1e-06	3.28e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—APOA1—atherosclerosis	4.1e-06	3.28e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	4.08e-06	3.27e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—MAPK3—atherosclerosis	4.06e-06	3.24e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	4.04e-06	3.23e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	4.02e-06	3.22e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CD36—atherosclerosis	4.02e-06	3.21e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	4e-06	3.2e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	3.99e-06	3.19e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	3.97e-06	3.18e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PPARG—atherosclerosis	3.96e-06	3.17e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	3.96e-06	3.17e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—TGFB1—atherosclerosis	3.93e-06	3.15e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	3.92e-06	3.13e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	3.91e-06	3.13e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	3.91e-06	3.13e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	3.9e-06	3.12e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	3.89e-06	3.11e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—INS—atherosclerosis	3.89e-06	3.11e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	3.88e-06	3.1e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	3.87e-06	3.09e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	3.85e-06	3.08e-05	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	3.85e-06	3.08e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	3.84e-06	3.07e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.81e-06	3.04e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	3.8e-06	3.04e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	3.79e-06	3.03e-05	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—IL6—atherosclerosis	3.79e-06	3.03e-05	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	3.79e-06	3.03e-05	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	3.78e-06	3.02e-05	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	3.77e-06	3.01e-05	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	3.76e-06	3e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.74e-06	2.99e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PPARA—atherosclerosis	3.73e-06	2.99e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—IL6—atherosclerosis	3.73e-06	2.98e-05	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—IL6—atherosclerosis	3.72e-06	2.97e-05	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	3.72e-06	2.97e-05	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	3.71e-06	2.97e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	3.71e-06	2.97e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—IL6—atherosclerosis	3.7e-06	2.96e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	3.67e-06	2.93e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	3.66e-06	2.93e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	3.65e-06	2.92e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	3.63e-06	2.9e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—AGT—atherosclerosis	3.62e-06	2.89e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PPARG—atherosclerosis	3.61e-06	2.89e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MMP9—atherosclerosis	3.6e-06	2.88e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.57e-06	2.85e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	3.57e-06	2.85e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	3.57e-06	2.85e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—ALB—atherosclerosis	3.56e-06	2.85e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MMP9—atherosclerosis	3.55e-06	2.84e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—APOE—atherosclerosis	3.54e-06	2.83e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—INS—atherosclerosis	3.54e-06	2.83e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MMP9—atherosclerosis	3.54e-06	2.83e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	3.53e-06	2.82e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MMP9—atherosclerosis	3.52e-06	2.81e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CAV1—atherosclerosis	3.51e-06	2.81e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	3.51e-06	2.81e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	3.51e-06	2.81e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	3.51e-06	2.8e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—APOA1—atherosclerosis	3.5e-06	2.8e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	3.5e-06	2.8e-05	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	3.5e-06	2.8e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	3.49e-06	2.79e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	3.48e-06	2.78e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	3.48e-06	2.78e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	3.48e-06	2.78e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	3.47e-06	2.78e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	3.47e-06	2.77e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	3.45e-06	2.76e-05	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	3.45e-06	2.76e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	3.45e-06	2.75e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	3.44e-06	2.75e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	3.44e-06	2.75e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	3.44e-06	2.75e-05	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	3.43e-06	2.74e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	3.43e-06	2.74e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	3.42e-06	2.74e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	3.42e-06	2.73e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—APOB—atherosclerosis	3.42e-06	2.73e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	3.41e-06	2.73e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—NOS3—atherosclerosis	3.41e-06	2.72e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	3.39e-06	2.71e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	3.39e-06	2.71e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	3.38e-06	2.7e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	3.38e-06	2.7e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	3.37e-06	2.69e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	3.37e-06	2.69e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.32e-06	2.66e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	3.32e-06	2.66e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—IL6—atherosclerosis	3.29e-06	2.63e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—LPL—atherosclerosis	3.26e-06	2.61e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—IL6—atherosclerosis	3.25e-06	2.6e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—ALB—atherosclerosis	3.25e-06	2.6e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	3.24e-06	2.59e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	3.23e-06	2.58e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	3.22e-06	2.58e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—STAT3—atherosclerosis	3.2e-06	2.56e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	3.2e-06	2.56e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	3.19e-06	2.55e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	3.18e-06	2.55e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GPX1—atherosclerosis	3.18e-06	2.55e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	3.18e-06	2.54e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	3.17e-06	2.53e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	3.16e-06	2.52e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—STAT3—atherosclerosis	3.15e-06	2.52e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—STAT3—atherosclerosis	3.15e-06	2.52e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	3.14e-06	2.51e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	3.14e-06	2.51e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	3.13e-06	2.5e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	3.13e-06	2.5e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—STAT3—atherosclerosis	3.13e-06	2.5e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	3.12e-06	2.49e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.12e-06	2.49e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—IL6—atherosclerosis	3.11e-06	2.49e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—NOS3—atherosclerosis	3.11e-06	2.48e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CD36—atherosclerosis	3.1e-06	2.48e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	3.1e-06	2.48e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	3.09e-06	2.47e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PPARG—atherosclerosis	3.09e-06	2.47e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	3.06e-06	2.45e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—AKT1—atherosclerosis	3.04e-06	2.43e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—INS—atherosclerosis	3.03e-06	2.42e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	3.01e-06	2.41e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	3.01e-06	2.4e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—AKT1—atherosclerosis	3e-06	2.4e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	3e-06	2.4e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	2.99e-06	2.39e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	2.97e-06	2.38e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—IL6—atherosclerosis	2.97e-06	2.37e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	2.96e-06	2.36e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	2.95e-06	2.36e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.94e-06	2.35e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—IL6—atherosclerosis	2.93e-06	2.34e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	2.92e-06	2.34e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	2.92e-06	2.33e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	2.91e-06	2.32e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	2.9e-06	2.32e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	2.9e-06	2.32e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PPARA—atherosclerosis	2.88e-06	2.3e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—AKT1—atherosclerosis	2.87e-06	2.29e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	2.87e-06	2.29e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	2.87e-06	2.29e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	2.86e-06	2.29e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.84e-06	2.27e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—AGT—atherosclerosis	2.79e-06	2.23e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ALB—atherosclerosis	2.78e-06	2.22e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	2.74e-06	2.19e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—AKT1—atherosclerosis	2.74e-06	2.19e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—APOE—atherosclerosis	2.74e-06	2.19e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CAV1—atherosclerosis	2.71e-06	2.17e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—APOA1—atherosclerosis	2.7e-06	2.16e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	2.7e-06	2.16e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	2.66e-06	2.13e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—NOS3—atherosclerosis	2.66e-06	2.12e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—IL6—atherosclerosis	2.54e-06	2.03e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.47e-06	1.97e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.43e-06	1.94e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	2.43e-06	1.94e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—AKT1—atherosclerosis	2.41e-06	1.93e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PPARG—atherosclerosis	2.38e-06	1.9e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	2.34e-06	1.87e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—INS—atherosclerosis	2.34e-06	1.87e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	2.24e-06	1.79e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—IL6—atherosclerosis	2.24e-06	1.79e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—AKT1—atherosclerosis	2.21e-06	1.77e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—IL6—atherosclerosis	2.2e-06	1.76e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—IL6—atherosclerosis	2.2e-06	1.76e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—IL6—atherosclerosis	2.19e-06	1.75e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL6—atherosclerosis	2.18e-06	1.75e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL6—atherosclerosis	2.16e-06	1.73e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	2.16e-06	1.72e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ALB—atherosclerosis	2.14e-06	1.71e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—AKT1—atherosclerosis	2.07e-06	1.65e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—NOS3—atherosclerosis	2.05e-06	1.64e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—AKT1—atherosclerosis	2.03e-06	1.62e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—AKT1—atherosclerosis	2.03e-06	1.62e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	2.02e-06	1.62e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—AKT1—atherosclerosis	2.01e-06	1.61e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	2e-06	1.6e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	2e-06	1.6e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	1.99e-06	1.59e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.87e-06	1.5e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	1.85e-06	1.48e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—AKT1—atherosclerosis	1.57e-06	1.25e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.43e-06	1.14e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.22e-06	9.76e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—AKT1—atherosclerosis	9.42e-07	7.53e-06	CbGpPWpGaD
